CY1107742T1 - Εισπνεομενα φαρμακευτικα προϊοντα που περιεχουν ενα νεο αντιχολινεργικο σε συνδυασμο με κορτικοστεροειδη και βητα-μιμητικα - Google Patents

Εισπνεομενα φαρμακευτικα προϊοντα που περιεχουν ενα νεο αντιχολινεργικο σε συνδυασμο με κορτικοστεροειδη και βητα-μιμητικα

Info

Publication number
CY1107742T1
CY1107742T1 CY20071101217T CY071101217T CY1107742T1 CY 1107742 T1 CY1107742 T1 CY 1107742T1 CY 20071101217 T CY20071101217 T CY 20071101217T CY 071101217 T CY071101217 T CY 071101217T CY 1107742 T1 CY1107742 T1 CY 1107742T1
Authority
CY
Cyprus
Prior art keywords
beta
combination
corticosteroid
inhalated
anticolinergic
Prior art date
Application number
CY20071101217T
Other languages
English (en)
Inventor
Michel Pairet
Christopher John Montague Meade
Michael Paul Pieper
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of CY1107742T1 publication Critical patent/CY1107742T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Η παρούσα εφεύρεση αφορά καινοτόμες φαρμακευτικές συνθέσεις με βάση ένα νέο αντιχολινεργικό, κορτικοστεροειδή και βήτα-μιμητικά, μέθοδο για την παραγωγή τους καθώς και τη χρήση τους στη θεραπεία παθήσεων των αναπνευστικών οδών.
CY20071101217T 2002-08-17 2007-09-19 Εισπνεομενα φαρμακευτικα προϊοντα που περιεχουν ενα νεο αντιχολινεργικο σε συνδυασμο με κορτικοστεροειδη και βητα-μιμητικα CY1107742T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10237739A DE10237739A1 (de) 2002-08-17 2002-08-17 Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
EP03793643A EP1530471B1 (de) 2002-08-17 2003-07-25 Inhalative arzneimittel enthaltend ein neues anticholinergikum in kombination mit corticosteroiden und betamimetika

Publications (1)

Publication Number Publication Date
CY1107742T1 true CY1107742T1 (el) 2013-04-18

Family

ID=30775387

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101217T CY1107742T1 (el) 2002-08-17 2007-09-19 Εισπνεομενα φαρμακευτικα προϊοντα που περιεχουν ενα νεο αντιχολινεργικο σε συνδυασμο με κορτικοστεροειδη και βητα-μιμητικα

Country Status (21)

Country Link
EP (2) EP1785136A3 (el)
JP (1) JP2006501253A (el)
KR (1) KR101083977B1 (el)
CN (1) CN1688308A (el)
AT (1) ATE366574T1 (el)
AU (1) AU2003255289B2 (el)
BR (1) BR0313526A (el)
CA (1) CA2495454C (el)
CO (1) CO5540380A2 (el)
CY (1) CY1107742T1 (el)
DE (2) DE10237739A1 (el)
DK (1) DK1530471T3 (el)
ES (1) ES2290549T3 (el)
IL (1) IL166891A (el)
MX (1) MXPA05001823A (el)
NZ (1) NZ538834A (el)
PL (1) PL212070B1 (el)
PT (1) PT1530471E (el)
RU (1) RU2332217C2 (el)
WO (1) WO2004022058A1 (el)
ZA (1) ZA200500019B (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7576001A (en) 2000-08-05 2002-02-18 Glaxo Group Ltd 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent
EP1383786B1 (en) 2001-04-30 2008-10-15 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024453A1 (de) * 2004-05-14 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases
US20060034776A1 (en) * 2004-08-10 2006-02-16 Boehringer Ingelheim International Gmbh Inhalable medicaments containing a new anticholinergic, corticosteroids, and betamimetics
DE102004056578A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid
DE102004056579A1 (de) * 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
SG159550A1 (en) 2005-02-25 2010-03-30 Chiesi Farma Spa Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
CA2603433A1 (en) * 2005-03-30 2006-10-05 Schering Corporation Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist
WO2006114379A1 (de) * 2005-04-23 2006-11-02 Boehringer Ingelheim International Gmbh Arzneimittelkombination für die inhalation enthaltend neben einem anticholinergikum ein betamimetikum und ein steroid
ES2530991T3 (es) 2005-08-15 2015-03-09 Boehringer Ingelheim Int Procedimiento para la obtención de betamiméticos
CA2701956A1 (en) * 2007-10-25 2009-04-30 Merck Frosst Canada Ltd. Combination therapy
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PL3106149T3 (pl) 2009-05-29 2020-06-01 Pearl Therapeutics, Inc. Kompozycje do płucnego dostarczania długo-działających antagonistów muskarynowych i długo-działających agonistów receptora beta-2 adrenergicznego oraz powiązane sposoby i układy
RU2479304C1 (ru) * 2012-05-29 2013-04-20 Шолекс Девелопмент Гмбх, Стабильный раствор фенотерола гидробромида
RU2504382C1 (ru) * 2012-06-13 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
WO2014096115A1 (en) 2012-12-21 2014-06-26 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
LT3473255T (lt) 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Farmacinė vaisto forma, apimanti ciklezonidą
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
WO2015065223A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Стабильный раствор фенотерола гидробромида
WO2015065220A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
PL3157522T3 (pl) * 2014-06-18 2020-03-31 Boehringer Ingelheim Vetmedica Gmbh Antagonisty muskarynowi i ich kombinacje do leczenia choroby dróg oddechowych u koni

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003935D0 (en) * 2000-02-08 2000-04-12 King S College London Formulation for dry powder inhaler
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika

Also Published As

Publication number Publication date
ZA200500019B (en) 2006-07-26
DK1530471T3 (da) 2007-10-22
EP1785136A2 (de) 2007-05-16
PL212070B1 (pl) 2012-08-31
PL375233A1 (en) 2005-11-28
CO5540380A2 (es) 2005-07-29
EP1530471B1 (de) 2007-07-11
AU2003255289B2 (en) 2009-08-20
IL166891A (en) 2010-04-15
RU2005107475A (ru) 2006-04-10
EP1785136A3 (de) 2009-04-22
MXPA05001823A (es) 2005-04-19
BR0313526A (pt) 2005-06-28
ES2290549T3 (es) 2008-02-16
EP1530471A1 (de) 2005-05-18
KR20050051644A (ko) 2005-06-01
CA2495454A1 (en) 2004-03-18
KR101083977B1 (ko) 2011-11-22
PT1530471E (pt) 2007-07-26
NZ538834A (en) 2007-10-26
WO2004022058A1 (de) 2004-03-18
DE50307659D1 (de) 2007-08-23
CN1688308A (zh) 2005-10-26
ATE366574T1 (de) 2007-08-15
AU2003255289A1 (en) 2004-03-29
CA2495454C (en) 2011-09-06
RU2332217C2 (ru) 2008-08-27
JP2006501253A (ja) 2006-01-12
DE10237739A1 (de) 2004-02-26

Similar Documents

Publication Publication Date Title
CY1107742T1 (el) Εισπνεομενα φαρμακευτικα προϊοντα που περιεχουν ενα νεο αντιχολινεργικο σε συνδυασμο με κορτικοστεροειδη και βητα-μιμητικα
NO20051287L (no) Aerosolformulering for inhalasjon som inneholder et anticholinergisk middel
Danahy et al. Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate.
AR035589A1 (es) Esteres de acido difenilmetilcarboxilico con efecto anticolinergico, un procedimiento para su preparacion, el uso de los mismos para la preparacion de un medicamento y los preparados farmaceuticos que los contienen
RU93058534A (ru) Применение производных тетрагидрокарбазола в качестве антагонистов 5-нт*001 рецептора, производные тетрагидрокарбазола, способ их получения, способ лечения и фармацевтическая композиция
Rischitelli et al. Safety and efficacy of controlled‐release oxycodone: a systematic literature review
DE50103666D1 (de) Kristallines monohydrat von tiotropiumbromid, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
PT1335728E (pt) Novas preparacoes farmaceuticas compostas com base em sais do tiotropio e sais do salmeterol
BR0312507A (pt) Composições de medicamentos à base de novos anticolinérgicos e inibidores de egfr-cinase
Bagley et al. Evolution of the 4‐anilidopiperidine class of opioid analgesics
AR059126A1 (es) Uso de sales de tiotropio en el tratamiento del asma persistente moderada
RU2008108302A (ru) Применение солей тиотропия для лечения тяжелых форм персистирующей астмы
ATE314366T1 (de) Neue ester hydroxy-substituierter stickstoffheterocyclen als antagonisten des muskarinischen m3 rezeptors, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
CA2258965A1 (en) Useful formulations of acid addition salt drugs
PT1526848E (pt) Antagonistas dos receptores de opióides em sistemas transdérmicos contendo buprenorfina
DE50305263D1 (de) Difurylglykolsäuretropenolester als anticholinergika
AR039634A1 (es) Medicamento que contiene betamimeticos y un anticolinergico
TH65935A (th) ยาซึ่งประกอบรวมด้วยสเตอรอยด์ และแอนตีโคลิเนอร์จิคตัวใหม่
Dimmitt et al. Pharmacokinetics of diltiazem and propranolol when administered alone and in combination
Baker et al. Normal pharmacokinetics of doxapramin in a patient with renal failure and hypothyroidism.
Mourouzis et al. Mepivacaine Alters Vascular Responsiveness to Vasoconstrictors in Aortic Rings from Normal and Aortic‐Banded Rats
JPS59168115U (ja) 測量用の測距ロ−プ巻取機
ITTO910279A0 (it) Procedimento per la preparazione dell'acido -metil-4-(2-metilpropil) benzeneacetico e dei suoi sali